News – Page 854 – Endpoints News

No surprise: After near unanimous adcomm, FDA rejects Eli Lilly bid to bring Jardiance to type 1 patients

6 years ago

Inundated by demand, Gilead halts individual emergency access to experimental Covid-19 drug

6 years ago

Covid-19 roundup: Italy death toll officially tops China; US company plans roll out of at-home specimen collection ...

6 years ago

FDA revamps adverse event reporting guidance for Covid-19

6 years ago

A key player behind 2 multibillion-dollar biotech M&A deals is back in the startup business

6 years ago

Charles Bancroft makes quick leap from Bristol Myers exec team to GSK; Medicxi adds two new partners to its team

6 years ago

J&J pitches its S1P1 MS drug into the regulatory ring as the competition heats up fast

6 years ago

InnoCare IPO oversubscribed 300x as Hong Kong investors turned to biotech amid runoff

6 years ago

No, Mr. President, you can’t just order up outbreak meds with the snap of your fingers

6 years ago

Biogen fires staffer who fled to China after she was infected in the biotech’s coronavirus outbreak

6 years ago

Drugmaker rethinks its decision to double price of a generic after Trump calls it a coronavirus lifesaver — reports

6 years ago

Biogen sues company allegedly selling aducanumab copycat; J&J takes on Novartis' MS franchise

6 years ago

A tropical disease doctor turns his sights on the coronavirus

6 years ago

Pfizer's JAK1 challenger to Dupixent shines in another PhIII, but safety issues still cast a shadow

6 years ago

FDA unveils guidance for Covid-19 trials

6 years ago

Doing deals in a time of coronavirus: Biotech CEO Bill Haney says 'you focus on the things that make a difference'

6 years ago

Biogen flags delays on Spinraza treatments as hospitals shift focus and resources to pandemic patients

6 years ago

GSK quietly reveals just how much cash they used to buy a chunk of the Bay Area's buzziest startup

6 years ago

New data from randomized trial dent HIV drug strategy against Covid-19

6 years ago

Covid-19 roundup: Fred Hutch cuts down further on lab work, Roche joins Regeneron and Sanofi in IL-6 trials, China ...

6 years ago

A Japanese flu drug gets upbeat reviews in China for blunting the impact of Covid-19 — and that is bolstering ...

6 years ago

Bayer fires employee who was spotted breaking quarantine in China

6 years ago

Insilico inks another deal with Sino Biopharma unit; Ramaswamy's Datavant to invest in the "patient journey"

6 years ago

Sage plots comeback plan for its experimental oral antidepressant

6 years ago

First page Previous page 851 852 853854855 856 857 Next page Last page